EUVIMEDEUVIMED entdecken
Crossref

Small-Angle X-ray Scattering as a Powerful Tool for Phase and Crystallinity Assessment of Monoclonal Antibody Crystallites in Support of Batch Crystallization

Patrick Larpent iD, Lorenzo Codan iD, Jameson R Bothe, Luca Iuzzolino iD, Suzette Pabit, Sudipta Gupta, Thierry Fischmann, Yongchao Su iD, Paul Reichert, Dirk Stueber iD, Aaron Cote

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Patrick Larpent und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Research and Development, MSD Werthenstein BioPharma GmbH, Industrie Nord 1, 6105 Schachen, Switzerland. Hauptthemen laut MEDLINE: Crystallization, Scattering, Small Angle, Antibodies, Monoclonal, X-Ray Diffraction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crystalline suspensions of monoclonal antibodies (mAbs) have great potential to improve drug substance isolation and purification on a large scale and to be used for drug delivery via high-concentration formulations. Crystalline mAb suspensions are expected to have enhanced chemical and physical properties relative to mAb solutions delivered intravenously, making them attractive candidates for subcutaneous delivery. In contrast to small molecules, the development of protein crystalline suspensions is not a widely used approach in the pharmaceutical industry. This is mainly due to the challenges in finding crystalline hits and the suboptimal physical properties of the resulting crystallites when hits are found. Modern advances in instrumentation and increased knowledge of mAb crystallization have, however, resulted in higher probabilities of discovering crystal forms and improving their particle properties and characterization. In this regard, physical, analytical characterization plays a central role in the initial steps of understanding and later optimizing the crystallization of mAbs and requires careful selection of the appropriate tools. This contribution describes a novel crystal structure of the antibody pembrolizumab and demonstrates the usefulness of small-angle X-ray scattering (SAXS) for characterizing its crystalline suspensions. It illustrates the advantages of SAXS when used to (i) confirm crystallinity and crystal phase of crystallites produced in batch mode; (ii) confirm crystallinity under various conditions and detect variations in crystal phases, enabling fine-tuning of the crystallizations for phase control across multiple batches; (iii) monitor the physical response and stability of the crystallites in suspension with regard to filtration and washing; and (iv) monitor the physical stability of the crystallites upon drying. Overall, this work highlights how SAXS is an essential tool for mAb crystallization characterization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CrystallizationScattering, Small AngleAntibodies, MonoclonalX-Ray Diffraction

Stichwörter der Autor:innen

batch crystallizationcrystal phasecrystalline suspensionmonoclonal antibodypembrolizumabprotein crystalsmall-angle X-ray scattering

Substanzen

Antibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Analytical Research and Development, MSD Werthenstein BioPharma GmbH, Industrie Nord 1, 6105 Schachen, Switzerland.
  • Department of Process Research and Development, MSD Werthenstein BioPharma GmbH, Industrie Nord 1, 6105 Schachen, Switzerland.
  • Department of Analytical Research and Development, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.
  • Department of Computational and Structural Chemistry, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
  • Department of Analytical Research and Development, Merck & Co., Inc., West Point, Pennsylvania 19486, United States.
  • Department of Protein and Structural Chemistry, Merck & Co., Inc., Kenilworth, New Jersey 07033, United States.

ORCID-Profile: Patrick Larpent, Lorenzo Codan, Luca Iuzzolino, Yongchao Su, Dirk Stueber

Zitieren

APA

Larpent, P., Codan, L., Bothe, J. R., Iuzzolino, L., Pabit, S., Gupta, S., Fischmann, T., Su, Y., Reichert, P., Stueber, D., & Cote, A. (2024). Small-Angle X-ray Scattering as a Powerful Tool for Phase and Crystallinity Assessment of Monoclonal Antibody Crystallites in Support of Batch Crystallization. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00418

Vancouver

Larpent P, Codan L, Bothe JR, Iuzzolino L, Pabit S, Gupta S, et al. Small-Angle X-ray Scattering as a Powerful Tool for Phase and Crystallinity Assessment of Monoclonal Antibody Crystallites in Support of Batch Crystallization. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00418

BibTeX
@article{Larpent2024,
  author = {Larpent, Patrick and Codan, Lorenzo and Bothe, Jameson R and Iuzzolino, Luca and Pabit, Suzette and Gupta, Sudipta and Fischmann, Thierry and Su, Yongchao and Reichert, Paul and Stueber, Dirk and Cote, Aaron},
  title = {Small-Angle X-ray Scattering as a Powerful Tool for Phase and Crystallinity Assessment of Monoclonal Antibody Crystallites in Support of Batch Crystallization},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00418}
}
Kostenlos starten →